From startups to legacy brands, you're making your mark. We're here to help.
Key Links
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Key Links
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Key Links
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Key Links
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on your own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
For Companies and Institutions
From startups to legacy brands, you're making your mark. We're here to help.
Serving the world's largest corporate clients and institutional investors, we support the entire investment cycle with market-leading research, analytics, execution and investor services.
Your partner for commerce, receivables, cross-currency, working capital, blockchain, liquidity and more.
Prepare for future growth with customized loan services, succession planning and capital for business equipment.
Providing investment banking solutions, including mergers and acquisitions, capital raising and risk management, for a broad range of corporations, institutions and governments.
For Individuals
A uniquely elevated private banking experience shaped around you.
Whether you want to invest on you own or work with an advisor to design a personalized investment strategy, we have opportunities for every investor.
Explore a variety of insights.
Key Links
Insights by Topic
Explore a variety of insights organized by different topics.
Key Links
Insights by Type
Explore a variety of insights organized by different types of content and media.
Key Links
We aim to be the most respected financial services firm in the world, serving corporations and individuals in more than 100 countries.
Key Links
Two years into the pandemic and one year into the post-Brexit era, U.K. business leaders are optimistic about their own revenues, profits and performance in 2022. That confidence wanes a bit when looking to the broader national or European economies.
Our 2022 Business Leaders Outlook: United Kingdom survey of British companies with revenues between £20 million and £2 billion found that more than three in five businesses are impacted “immensely” or “largely” by Brexit, with lingering supply chain disruptions as the most common symptom.
The uncertainty brought by the omicron variant didn’t dim executives’ sunny outlook. The survey found 77% of midsize companies expect profits to meet or surpass pre-pandemic levels, and roughly 80% say they’re bullish about their own companies and industries.
"The past two years have helped midsize business leaders learn how to adapt and prepare for any crisis, and as a result, they’re entering the new year with renewed confidence and high growth expectations."
Viswas Raghavan
Chief Executive Officer EMEA, J.P. Morgan
Two-thirds (66%) of business executives said they’re optimistic about the global economy. Fewer felt as positive about the European (61%) or national economies (57%). Only 1% of business leaders expressed fear their companies may not survive.
More than two-thirds of business leaders surveyed are planning a full or partial transfer of their businesses, often to family or through a sale to a third party. Half of those leaders plan the transition to occur in the next two years.
© 2022 JPMorgan Chase & Co. All rights reserved. JPMorgan Chase Bank, N.A. Member FDIC. Visit jpmorgan.com/cb-disclaimer for disclosures and disclaimers related to this content.
Outlook
December 2024 jobs report: 256,000 jobs added, a strong finish to the year
Jan 13, 2025
December’s jobs report confirms that this is a strong economy that doesn’t currently need meaningful policy easing to see continued expansion, according to our strategists.
Outlook
Biopharma and medtech investments end 2024 on a high note
Jan 09, 2025
Our Biopharma and Medtech Licensing and Venture Reports explore upfront cash, mergers, acquisitions and other trends seen in the fourth quarter of 2024.
Outlook
Economic confidence snaps into focus
Jan 07, 2025
Middle market leaders report strongest optimism levels since 2019, as recession concerns fade and growth outlooks improve.
Outlook
Eye on the Market outlook 2025: The alchemists
Jan 03, 2025
Deregulation, deportations, tariffs, tax cuts, cost cutting, crypto, oil & gas, medical freedom and Agency purges: What could possibly go wrong?
Outlook
Dec 19, 2024
The Fed's statement introduced a new qualifier on the "extent and timing" of future rate cuts, suggesting a slower pace in 2025 than previously anticipated.
Outlook
Dec 17, 2024
In her end of year note, CEO of J.P. Morgan Wealth Management Kristin Lemkau reflects on markets in 2024 and looks forward to what might unfold in 2025.
Outlook
November 2024 CPI Report: Inflation readings largely match expectations
Dec 12, 2024
Though higher than the Federal Reserve’s target of two percent inflation, the November CPI print was no cause for alarm.
Outlook
Eye on the Market: The year of living dangerously
Dec 11, 2024
In this edition of Eye on the Market, Michael Cembalest, Chairman of Market and Investment Strategy for J.P. Morgan Asset and Wealth Management, discusses potential dangers related to 2025 predictions, allocations, apparitions, legalizations, expurgations and ablations.
You're now leaving J.P. Morgan
J.P. Morgan’s website and/or mobile terms, privacy and security policies don’t apply to the site or app you're about to visit. Please review its terms, privacy and security policies to see how they apply to you. J.P. Morgan isn’t responsible for (and doesn’t provide) any products, services or content at this third-party site or app, except for products and services that explicitly carry the J.P. Morgan name.